A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)

A Phase III Clinical Trial to Study the Safety, Tolerability and Immunogenicity of Zoster Vaccine Live in Subjects With a History of Herpes Zoster

The purpose of this study is to determine whether the investigational zoster vaccine, is generally well tolerated when administered to participants with a history of herpes zoster.

Inclusion Criteria:

• Adults ≥ 50 years of age with a history of herpes zoster ≥ 5 years prior to enrollment

Exclusion Criteria:

• History of allergy to any vaccine component
• Prior receipt of a varicella or zoster vaccine
• Ability to defend against infection is suppressed by a medical condition or medication